EMEA Revises Quality Review of Documents Templates

Drug Industry Daily
A A
Drugmakers submitting new applications for marketing authorization in the EU and using the European Medicines Agency’s (EMEA) centralized procedure should comply with a revision of the Quality Review of Documents (QRD) template as soon as possible, the agency says.

To View This Article:

Login

Subscribe To Drug Industry Daily